Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)
1.467
+0.117
(+8.67%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Mar 17, 2025
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
February 20, 2025
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
February 11, 2025
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
February 06, 2025
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
February 05, 2025
Lexaria Releases Annual Letter from the CEO
January 30, 2025
Lexaria Bioscience Earnings Analysis: Q1 Recap
January 10, 2025
Lexaria's Registered GLP-1 Study #4 Begins Dosing
December 19, 2024
Lexaria Forms New Scientific Advisory Board
December 18, 2024
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
November 25, 2024
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Frequently Asked QuestionsIs Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 1.467
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 03/17/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|